Species cross-reactivity of rheumatoid factors and implications for immunoassays

References

• Chan CP, Cheung YC, Renneberg R, Seydack M. New trends in immunoassays. Adv Biochem Eng Biotechnol 2008;109:123–54.
   PubMed Web of Science ®Google Scholar
• Borrebaeck CA. Antibodies in diagnostics – from immunoassays to protein chips. Immunol Today 2000;21:379–82.
   PubMedGoogle Scholar
• Johnstone AP, Turner MW (eds). Immunochemistry 1 & 2. Oxford, UK: Oxford University Press; 1997.
   Google Scholar
• Wild D, editor. The immunoassay handbook. Oxford, UK: Elsevier; 2013.
   Google Scholar
• Mageed RA, Børretzen M, Moyes SP, Thompson KM, Natvig JB. Rheumatoid factor autoantibodies in health and disease. Ann NY Acad Sci 1997;815:296–311.
   PubMedGoogle Scholar
• Dörner T, Egerer K, Feist E, Burmester GR. Rheumatoid factor revisited. Curr Opin Rheumatol 2004;16:246–53.
   PubMed Web of Science ®Google Scholar
• Newkirk MM. Rheumatoid factors: host resistance or autoimmunity? Clin Immunol 2002;104:1–13.
   PubMed Web of Science ®Google Scholar
• Vander Cruyssen B, Peene I, Cantaert T, Hoffman IE, De Rycke L, Veys EM, De Keyser F. Anti-citrullinated protein/peptide antibodies (ACPA) in rheumatoid arthritis: specificity and relation with rheumatoid factor. Autoimmun Rev 2005;4:468–74.
   PubMedGoogle Scholar
• Mjaavatten MD, van der Heijde D, Uhlig T, Haugen AJ, Nygaard H, Sidenvall G, Helgetveit K, Kvien TK. The likelihood of persistent arthritis increases with the level of anti-citrullinated peptide antibody and immunoglobulin M rheumatoid factor: a longitudinal study of 376 patients with very early undifferentiated arthritis. Arthritis Res Ther 2010;12:R76.
   Google Scholar
• Pruijn GJ, Wiik A, van Venrooij WJ. The use of citrullinated peptides and proteins for the diagnosis of rheumatoid arthritis. Arthritis Res Ther 2010;12:203.
   PubMed Web of Science ®Google Scholar
• Taylor P, Gartemann J, Hsieh J, Creeden J. A systematic review of serum biomarkers anti-cyclic citrullinated Peptide and rheumatoid factor as tests for rheumatoid arthritis. Autoimmune Dis 2011;815038:1–18.
   Google Scholar
• Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JM, Hobbs K, Huizinga TW, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, Ménard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, Tak PP, Upchurch KS, Vencovský J, Wolfe F, Hawker G. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010;62: 2569–81.
   PubMed Web of Science ®Google Scholar
• Corper AL, Sohi MK, Bonagura VR, Steinitz M, Jefferis R, Feinstein A, Beale D, Taussig MJ, Sutton BJ. Structure of human IgM rheumatoid factor Fab bound to its autoantigen IgG Fc reveals a novel topology of antibody-antigen interaction. Nat Struct Biol 1997;4:374–81.
   PubMedGoogle Scholar
• Duquerroy S, Stura EA, Bressanelli S, Fabiane SM, Vaney MC, Beale D, Hamon M, Casali P, Rey FA, Sutton BJ, Taussig MJ. Crystal structure of a human autoimmune complex between IgM rheumatoid factor RF61 and IgG1 Fc reveals a novel epitope and evidence for affinity maturation. J Mol Biol 2007;368:1321–31.
   PubMed Web of Science ®Google Scholar
• Painter PC, Lyon JM, Evans JH, Powers WW, Whittaker RL, Decker MJ. Performance of a new rate-nephelometric assay for rheumatoid factor, and its correlation with tube-titer results for human sera and synovial fluid. Clin Chem 1982;28:2214–8.
   PubMedGoogle Scholar
• Spiritus T, Verschueren P, Westhovens R, Bossuyt X. Diagnostic characteristics of a gelatin based Waaler-Rose assay (Serodia-RA) for the detection of rheumatoid factor. Ann Rheum Dis 2004;63:1169–71.
   PubMedGoogle Scholar
• Nikolaisen C, Rekvig OP, Nossent HC. Rheumatoid factor by laser nephelometry and Waaler-Rose assay: prognostic value in patients with recent-onset rheumatoid arthritis. Scand J Rheumatol 2005;34:269–76.
   PubMed Web of Science ®Google Scholar
• Roberts-Thomson PJ, McEvoy R, Langhans T, Bradley J. Routine quantification of rheumatoid factor by rate nephelometry. Ann Rheum Dis 1985;44:379–83.
   PubMedGoogle Scholar
• Finley PR, Hicks MJ, Williams RJ, Hinlicky J, Lichti DA. Rate nephelometric measurement of rheumatoid factor in serum. Clin Chem 1979;25:1909–14.
   PubMed Web of Science ®Google Scholar
• Bampton JL, Cawston TE, Kyle MV, Hazleman BL. Measurement of rheumatoid factors by an enzyme-linked immunosorbent assay (ELISA) and comparison with other methods. Ann Rheum Dis 1985;44:13–9.
   PubMed Web of Science ®Google Scholar
• Kleveland G, Egeland T, Lea T. Quantitation of rheumatoid factors (RF) of IgM, IgA and IgG isotypes by a simple and sensitive ELISA. Discrimination between false and true IgG-RF. Scand J Rheumatol Suppl 1988;75:15–24.
   PubMedGoogle Scholar
• Silvestris F, Goodwin JS, Williams RC Jr. IgM, IgA and IgG rheumatoid factors in patients with rheumatoid arthritis and normal donors. Clin Rheumatol 1985;4:392–8.
   PubMed Web of Science ®Google Scholar
• Gioud-Paquet M, Auvinet M, Raffin T, Girard P, Bouvier M, Lejeune E, Monier JC. IgM rheumatoid factor (RF), IgA RF, IgE RF, and IgG RF detected by ELISA in rheumatoid arthritis. Ann Rheum Dis 1987;46:65–71.
   PubMed Web of Science ®Google Scholar
• Procaccia S, Gasparini A, Colucci A, Lanzanova D, Bianchi M, Forcellini P, Villa P, Blasio R, Zanussi C. ELISA determined IgM, IgG and IgA rheumatoid factors in rheumatoid arthritis and in other connective tissue diseases. Clin Exp Rheumatol 1987;5:335–42.
   PubMedGoogle Scholar
• van Leeuwen MA, Westra J, Limburg PC, de Jong HJ, Marrink J, van Rijswijk MH. Quantitation of IgM, IgA and IgG rheumatoid factors by ELISA in rheumatoid arthritis and other rheumatic disorders. Scand J Rheumatol Suppl 1988;75:25–31.
   PubMedGoogle Scholar
• Varbanova BB, Baleva M, Nikolov K, Mihailova D. Prevalence of IgM-, IgA- and IgG-rheumatoid factors in seronegative polyarticular disease compared to pauciarticular disease in juvenile chronic arthritis as measured by ELISA. Adv Exp Med Biol 1999;455:61–8.
   PubMedGoogle Scholar
• Teitsson I, Valdimarsson H. Use of monoclonal antibodies and F(ab’)2 enzyme conjugates in ELISA for IgM, IgA and IgG rheumatoid factors. J Immunol Methods 1984;71: 149–61.
   PubMed Web of Science ®Google Scholar
• Swedler W, Wallman J, Froelich CJ, Teodorescu M. Routine measurement of IgM, IgG, and IgA rheumatoid factors: high sensitivity, specificity, and predictive value for rheumatoid arthritis. J Rheumatol 1997;24:1037–44.
   PubMedGoogle Scholar
• Todd DJ, Knowlton N, Amato M, Frank MB, Schur PH, Izmailova ES, Roubenoff R, Shadick NA, Weinblatt ME, Centola M, Lee DM. Erroneous augmentation of multiplex assay measurements in patients with rheumatoid arthritis due to heterophilic binding by serum rheumatoid factor. Arthritis Rheum 2011;63:894–903.
   PubMed Web of Science ®Google Scholar
• Bartels EM, Falbe Wätjen I, Littrup Andersen E, Danneskiold-Samsøe B, Bliddal H, Ribel-Madsen S. Rheumatoid factor and its interference with cytokine measurements: problems and solutions. Arthritis 2011; 2011:741071.
   PubMedGoogle Scholar
• Churchman SM, Geiler J, Parmar R, Horner EA, Church LD, Emery P, Buch MH, McDermott MF, Ponchel F. Multiplexing immunoassays for cytokine detection in the serum of patients with rheumatoid arthritis: lack of sensitivity and interference by rheumatoid factor. Clin Exp Rheumatol 2012;30:534–42.
   PubMedGoogle Scholar
• Bartels EM, Ribel-Madsen S. Cytokine measurements and possible interference from heterophilic antibodies-problems and solutions experienced with rheumatoid factor. Methods 2013;61:18–22.
   PubMed Web of Science ®Google Scholar
• Bjerner J, Nustad K, Norum LF, Olsen KH, Børmer OP. Immunometric assay interference: incidence and prevention. Clin Chem 2002;48:613–21.
   PubMed Web of Science ®Google Scholar
• Kazmierczak SC, Catrou PG, Briley KP. Transient nature of interference effects from heterophile antibodies: examples of interference with cardiac marker measurements. Clin Chem Lab Med 2000;38: 33–9.
   PubMedGoogle Scholar
• Wickus GG, Caplan RH, Mathews EA, Pehling GB. Sudden appearance and subsequent disappearance of interference in immunometric assays of thyrotropin neutralizable with purified mouse IgG. Clin Chem 1991;37:595–6.
   PubMedGoogle Scholar
• Kricka LJ. Human anti-animal antibody interferences in immunological assays. Clin Chem 1999;45:942–56.
   PubMed Web of Science ®Google Scholar
• Hennig C, Rink L, Fagin U, Jabs WJ, Kirchner H. The influence of naturally occurring heterophilic anti-immunoglobulin antibodies on direct measurement of serum proteins using sandwich ELISAs. J Immunol Methods 2000;235:71–80.
   PubMed Web of Science ®Google Scholar
• Levinson SS, Miller JJ. Towards a better understanding of heterophile (and the like) antibody interference with modern immunoassays. Clin Chim Acta 2002;325:1–15.
   PubMed Web of Science ®Google Scholar
• Tate J, Ward G. Interferences in immunoassay. Clin Biochem Rev 2004;25:105–20.
   PubMedGoogle Scholar
• Andersen DC, Koch C, Jensen CH, Skjødt K, Brandt J, Teisner B. High prevalence of human anti-bovine IgG antibodies as the major cause of false positive reactions in two-site immunoassays based on monoclonal antibodies. J Immunoassay Immunochem 2004;25:17–30.
   PubMed Web of Science ®Google Scholar
• de Jager W, Prakken BJ, Bijlsma JW, Kuis W, Rijkers GT. Improved multiplex immunoassay performance in human plasma and synovial fluid following removal of interfering heterophilic antibodies. J Immunol Methods 2005;300: 124–35.
   PubMed Web of Science ®Google Scholar
• DeForge LE, Loyet KM, Delarosa D, Chinn J, Zamanian F, Chuntharapai A, Lee J, Hass P, Wei N, Townsend MJ, Wang J, Wong WL. Evaluation of heterophilic antibody blocking agents in reducing false positive interference in immunoassays for IL-17AA, IL-17FF, and IL-17AF. J Immunol Methods 2010;362:70–81.
   PubMedGoogle Scholar
• Degn SE, Andersen SH, Jensen L, Thiel S, Jensenius JC. Assay interference caused by antibodies reacting with rat kappa light-chain in human sera. J Immunol Meth 2011; 372:204–8.
   PubMed Web of Science ®Google Scholar
• Bolstad N, Warren D, Nustad K. Heterophilic antibody interference in immunometric assays. Best Pract Res Clin Endocrinol Met 2013;27:647–61.
   PubMed Web of Science ®Google Scholar
• Burastero SE, Casali P, Wilder RL, Notkins AL. Monoreactive high affinity and polyreactive low affinity rheumatoid factors are produced by CD5 + B cells from patients with rheumatoid arthritis. J Exp Med 1988;168:1979–92.
   PubMed Web of Science ®Google Scholar
• Levinson SS. Antibody multispecificity in immunoassay interference. Clin Biochem 1992;25:77–87.
   PubMedGoogle Scholar
• Kragstrup, TW, Vorup-Jensen T, Deleuran B, Hvid M. A simple set of validation steps identifues and removes false results in a sandwich enzyme-linked immunosorbent assay caused by anti-animal IgG antibodies in plasma from arthritis patients. SpringerPlus 2013;2;263.
   PubMed Web of Science ®Google Scholar
• Turpeinen U, Lehtovirta P, Alfthan H, Stenman UH. Interference by human anti-mouse antibodies in CA 125 assay after immunoscintigraphy: anti-idiotypic antibodies not neutralized by mouse IgG but removed by chromatography. Clin Chem 1990;36:1333–38.
   PubMed Web of Science ®Google Scholar
• Boerman OC, Segers MF, Poels LG, Kenemans P, Thomas CM. Heterophilic antibodies in human sera causing falsely increased results in the CA 125 immunofluorometric assay. Clin Chem 1990;36:888–91.
   PubMed Web of Science ®Google Scholar
• Kuroki M, Matsumoto Y, Arakawa F, Haruno M, Murakami M, Kuwahara M, Ozaki H, Senba, T, Matsuoka Y. Reducing interference from heterophilic antibodies in a two-site immunoassay for carcinoembryonic antigen (CEA) by using a human/mouse chimeric antibody to CEA as the tracer. J Immunol Methods 1995;180: 81–91.
   PubMed Web of Science ®Google Scholar
• Padova G, Briguglia G, Tita P, Munguira ME, Arpi ML, Pezzino V. Hypergonadotropinemia not associated to ovarian failure and induced by factors interfering in radioimmunoassay. Fertil Steril 1991;55:637–39.
   PubMedGoogle Scholar
• Jockenhovel F, Khan SA, Nieschlag E. Circulating antibodies to monoclonal immunoglobulins used in a follitropin assay may cause incorrect fertility diagnosis. J Clin Chem Clin Biochem 1989;27:825–28.
   PubMedGoogle Scholar
• Fitzmaurice TF, Brown C, Rifai N, Wu AHB, Yeo K-TJ. False increase of cardiac troponin I with heterophilic antibodies. Clin Chem 1998;44:2212–14.
   PubMedGoogle Scholar
• Zweig MH, Csako G, Benson CC, Weintraub BD, Kahn BB. Interference by anti-immunoglobulin G antibodies in immunoradiometric assays of thyrotropin involving mouse monoclonal antibodies. Clin Chem 1987;33: 840–44.
   PubMedGoogle Scholar
• Sampson M, Ruddel M, Zweig M, Elin RJ. Falsely high concentration of serum lutropin measured with the Abbott IMx. Clin Chem 1994;40:1976–77.
   PubMedGoogle Scholar
• Azrin MA. The use of antibodies in clinical cardiology. Am Heart J 1992;124:753–68.
   PubMedGoogle Scholar
• Wijdenes J, Roy C, Morel-Fourrier B, Racadot E. Monoclonal antibodies in human organ transplantation and auto-immune diseases. Therapie 1992;47:283–87.
   PubMedGoogle Scholar
• Bischof Delaloye A, Delaloye B. Diagnostic applications and therapeutic approaches with different preparations of anti-CEA antibodies. Int J Biol Markers 1992;7:193–97.
   PubMedGoogle Scholar
• Greiner JW, Guadagni F, Hand PH, Pestka S, Noguchi P, Fisher PB, Schlom J. Augmentation of tumor antigen expression by recombinant human interferons: enhanced targeting of monoclonal antibodies to carcinomas. Cancer Treat Res 1990;51:413–32.
   PubMedGoogle Scholar
• Hoffman T. Anticipating, recognizing, and preventing hazards associated with in vivo use of monoclonal antibodies: special considerations related to human anti-mouse antibodies. Cancer Res 1990;50:1049–50.
   Google Scholar
• Dillman RO. Antibodies as cytotoxic therapy. J Clin Oncol 1994;12:1497–1515.
   PubMed Web of Science ®Google Scholar
• Ballow M, Nelson R. Immunopharmacology: immunomodulation and immunotherapy. JAMA 1997;278:2008–17.
   PubMed Web of Science ®Google Scholar
• Laursen I, Blou L, Sullivan JS, Bang P, Balstrup F, Houen G. Development, manufacturing and characterization of a highly purified, liquid immunoglobulin G preparation from human plasma. Trans Med Hemost 2014;41:205–12.
   PubMedGoogle Scholar
• Skogstrand K, Thorsen P, Nørgaard-Pedersen B, Schendel DE, Sørensen LC, Hougaard DM. Simultaneous measurement of 25 inflammatory markers and neurotrophins in neonatal dried blood spots by immunoassay with xMAP technology. Clin Chem 2005;51:1854–66.
   PubMed Web of Science ®Google Scholar
• Høier-Madsen M, Nielsen LP, Møller S. Determination of IgM rheumatoid factor by enzyme-linked immunosorbent assay (ELISA). Dan Med Bull 1986;148:2018–21.
   Google Scholar
• Svendsen CB, Hummelshøj T, Munthe-Fog L, Milman N, Garred P, Laursen IA, Christiansen M, Krogfelt KA. Ficolins and mannose-binding lectin in Danish patients with sarcoidosis. Resp Med 2008;102:1237–42.
   PubMed Web of Science ®Google Scholar
• Pabst O, Mowat AM. Oral tolerance to food protein. Mucosal Immunol 2012;5:232–9.
   PubMed Web of Science ®Google Scholar
• Faria AM, Gomes-Santos AC, Gonçalves JL, Moreira TG, Medeiros SR, Dourado LP, Cara DC. Food components and the immune system: from tonic agents to allergens. Front Immunol 2013;4:102.
   PubMedGoogle Scholar
• Husby S. Dietary antigens: uptake and humoral immunity in man. APMIS Suppl. 1988;1:1–40.
   PubMedGoogle Scholar